Dimitrios Daoussis

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 22

Top Topics

Interstitial Lung Disease

Systemic Sclerosis

Atopic Dermatitis

Top Venues

Rheumatology international

Clinical rheumatology

International journal of molecular sciences

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Ioannis Kouverianos, Andreas Angelopoulos, Dimitrios Daoussis
The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review. Rheumatology international 43 (7) (2023)
Ioannis Kouverianos, Andreas Angelopoulos, Dimitrios Daoussis
The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review. Rheumatology international (2023)
Ioannis Sagonas, Dimitrios Daoussis
Treatment of digital ulcers in systemic sclerosis: recent developments and future perspectives. Clinical rheumatology (2023)
Ioannis Kouverianos, Andreas Angelopoulos, Dimitrios Daoussis
The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review. Rheumatology international 43 (7) (2023)
Ioannis Kouverianos, Andreas Angelopoulos, Dimitrios Daoussis
The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review. Rheumatology international 43 (7) (2023)
Ioannis Kouverianos, Andreas Angelopoulos, Dimitrios Daoussis
The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review. Rheumatology international (2023)
Ioannis Kouverianos, Andreas Angelopoulos, Dimitrios Daoussis
The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review. Rheumatology international (2023)
Ioannis Kouverianos, Andreas Angelopoulos, Dimitrios Daoussis
The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review. Rheumatology international 43 (7) (2023)
Ioannis Kouverianos, Andreas Angelopoulos, Dimitrios Daoussis
The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review. Rheumatology international (2023)
Dimitrios Daoussis, Panagiotis Kordas, George Varelas, Marina A Michalaki, Anny Onoufriou, Irene Mamali, George Iliopoulos, Konstantinos Melissaropoulos, Konstantinos Ntelis, Dimitrios Velissaris, Giannis Tzimas, Panagiotis Georgiou, Sofia Vamvakopoulou, Fotini Paliogianni, Andrew P Andonopoulos, Neoklis Georgopoulos
ACTH vs steroids for the treatment of acute gout in hospitalized patients: a randomized, open label, comparative study. Rheumatology international 42 (6) (2022)
Dimitrios Daoussis, Anastasia Kanellou, Elias Panagiotopoulos, Dionysios J Papachristou
DKK-1 Is Underexpressed in Mesenchymal Stem Cells from Patients with Ankylosing Spondylitis and Further Downregulated by IL-17. International journal of molecular sciences 23 (12) (2022)
Ioanna Nefeli Kokloni, Souzana Ioanna Aligianni, Olga E Makri, Dimitrios Daoussis
Vision loss in giant cell arteritis: case-based review. Rheumatology international 42 (10) (2022)
George Iliopoulos, Dimitrios Daoussis
Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis. Rheumatology international 41 (7) (2021)
Konstantinos Melissaropoulos, Dimitrios Daoussis
B cells in systemic sclerosis: from pathophysiology to treatment. Clinical rheumatology 40 (7) (2021)
Dimitrios Daoussis, Leonidia Leonidou, Christina Kalogeropoulou, Fotini Paliogianni, Argyrios Tzouvelekis
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed. Rheumatology international 41 (10) (2021)
Dimitrios Daoussis, Pantelis Kraniotis, Foteini Kalofonou, Haralabos Kalofonos
Anti-PD-1 associated retroperitoneal fibrosis. Rheumatology (Oxford, England) 60 (9) (2021)
Konstantinos Melissaropoulos, Kalliopi Klavdianou, Alexandra Filippopoulou, Fotini Kalofonou, Haralabos Kalofonos, Dimitrios Daoussis
Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors. International journal of molecular sciences 21 (9) (2020)
Foteini Angelopoulou, Dimitrios Petros Bogdanos, Theodoros Dimitroulas, Lazaros I Sakkas, Dimitrios Daoussis
Immune checkpoint inhibitor-induced musculoskeletal manifestations. Rheumatology international 41 (1) (2020)
Athanasios Gkoutzourelas, Christos Liaskos, Theodora Simopoulou, Christina G Katsiari, George Efthymiou, Thomas Scheper, Wolfgang Meyer, Alexandra Tsirogianni, Christina Tsigalou, Efthimios Dardiotis, Dimitrios Daoussis, Lazaros I Sakkas, Dimitrios Petros Bogdanos
A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies. Rheumatology international 40 (10) (2020)
Dimitrios Daoussis, Dimitrios Petros Bogdanos, Theodoros Dimitroulas, Lazaros I Sakkas, Andrew P Andonopoulos
Adrenocorticotropic hormone: an effective "natural" biologic therapy for acute gout? Rheumatology international 40 (12) (2020)
Konstantinos Melissaropoulos, Pantelis Kraniotis, Dimitrios Petros Bogdanos, Theodoros Dimitroulas, Lazaros I Sakkas, Dimitrios Daoussis
Targeting very early systemic sclerosis: a case-based review. Rheumatology international 39 (11) (2019)
Eleni Pagkopoulou, Alexandra Arvanitaki, Dimitrios Daoussis, Alexandros Garyfallos, George D Kitas, Theodoros Dimitroulas
Comorbidity burden in systemic sclerosis: beyond disease-specific complications. Rheumatology international 39 (9) (2019)